Show simple item record

dc.creatorCharlton, Bruce G.en
dc.date.accessioned2016-01-08T23:47:21Zen
dc.date.available2016-01-08T23:47:21Zen
dc.date.created2005en
dc.date.issued2005en
dc.identifierdoi:10.1016/j.mehy.2005.08.013en
dc.identifier.bibliographicCitationMedical Hypotheses 2005; 65(6): 1005-1009en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=If+'atypical'+neuroleptics+did+not+exist,+it+wouldn't+be+necessary+to+invent+them:+perverse+incentives+in+drug+development,+research,+marketing+and+clinical+practice&title=Medical+Hypotheses+&volume=65&issue=6&spage=1005-1009&date=2005&au=Charlton,+Bruce+G.en
dc.identifier.urihttp://dx.doi.org/10.1016/j.mehy.2005.08.013en
dc.identifier.urihttp://hdl.handle.net/10822/985608en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:279307en
dc.subjectIncentivesen
dc.subjectMarketingen
dc.subjectResearchen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationPsychopharmacologyen
dc.titleIf 'Atypical' Neuroleptics Did Not Exist, It Wouldn't Be Necessary to Invent Them: Perverse Incentives in Drug Development, Research, Marketing and Clinical Practiceen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885